Low levels of K ATP channel activation decrease excitability and contractility of urinary bladder. Am J Physiol Regulatory Integrative Comp Physiol 280: R1427-R1433, 2001.-Activation of ATP-sensitive potassium (K ATP) channels can regulate smooth muscle function through membrane potential hyperpolarization. A critical issue in understanding the role of K ATP channels is the relationship between channel activation and the effect on tissue function. Here, we explored this relationship in urinary bladder smooth muscle (UBSM) from the detrusor by activating K ATP channels with the synthetic compounds N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide (ZD-6169) and levcromakalim. The effects of ZD-6169 and levcromakalim on K ATP channel currents in isolated UBSM cells, on action potentials, and on related phasic contractions of isolated UBSM strips were examined. ZD-6169 and levcromakalim at 1.02 and 2.63 M, respectively, caused half-maximal activation (K 1/2) of KATP currents in single UBSM cells (see Heppner TJ, Bonev A, Li JH, Kau ST, and Nelson MT. Pharmacology 53: [170][171][172][173][174][175][176][177][178][179] 1996). In contrast, much lower concentrations (K 1/2 ϭ 47 nM for ZD-6169 and K 1/2 ϭ 38 nM for levcromakalim) caused inhibition of action potentials and phasic contractions of UBSM. The results suggest that activation of Ͻ1% of K ATP channels is sufficient to inhibit significantly action potentials and the related phasic contractions.
ZD-6169; levcromakalim; incontinence; electrophysiology; guinea pig; potassium channel openers URINARY BLADDER SMOOTH MUSCLE (UBSM) from the detrusor exhibits spontaneous action potentials (3, 8) , which are thought to underlie the nature of spontaneous phasic contractions in this tissue. Excitability in UBSM and the subsequent contractions are dependent on Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels (3, 17) . The repolarization of the action potential depends in part on activation of iberiotoxin-sensitive, large-conductance, Ca 2ϩ -activated K ϩ (K Ca ) channels (8) , and the afterhyperpolarization is caused by activation of apamin-sensitive, small-conductance K Ca channels (4, 9, 14) . Thus cell excitability, and therefore cytosolic Ca 2ϩ concentration, can be decreased through the activation of K ϩ channels that act to hyperpolarize the membrane potential and decrease action potential frequency.
UBSM contains different types of K ϩ channels (3, 8, 15) , including ATP-sensitive K ϩ (K ATP ) channels that can be activated by a variety of potassium channel openers (KCOs) (1, 5, 6, 12-14, 22, 25) . In tonic smooth muscle, such as vascular smooth muscle, KCOs, including pinacidil, cromakalim, and levcromakalim activate K ATP channels with one-half activation of the currents in the 1-3 M range (20, 21) . However, KCOs cause vasodilation at lower concentrations than are required for one-half activation of whole cell K ATP currents. These compounds cause one-half relaxation of isolated vessels in the concentration range of 30-600 nM (20, 21, 26) . This observation suggests that a small increase in K ATP -channel conductance can have a large effect on the cell membrane potential and smooth muscle tone (18, 21) . Unlike vascular smooth muscle, UBSM exhibits action potentials and phasic contractions. Therefore, we hypothesized that UBSM may be very sensitive to KCOs because small changes in K ATP -channel conductance are likely to move the resting membrane potential away from the threshold of action potential activation, and thus have significant inhibitory effects on action potentials and related phasic contractions.
Trivedi et al. (24) and Howe et al. (11) described a new bladder-selective KCO, ZD-6169, the S-enantiomer of the racemic compound N-(4-benzoylphenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide, which opens K ATP channels in guinea pig detrusor (7, 16) and hyperpolarizes the membrane potential through K ATP channel activation (7, 16, 24) . ZD-6169 and levcromakalim effectively inhibit K ϩ -induced contractions of guinea pig bladder (5, 16) . ZD-6169 is also highly effective at inhibiting spontaneous contractions of rat bladder in vivo (25) . However, the effects of KCOs, and ZD-6169 in particular, have not been studied on UBSM action potentials and phasic contractions in physiological external K ϩ solution. The goal of the present study was to determine the degree of K ATP channel activation required to inhibit action potentials and related phasic contractions of UBSM using ZD-6169 and levcromakalim as KCOs. We found that ZD-6169 and levcromakalim at concentrations Ͼ10 nM inhibited action potentials and contractions. These findings suggest a direct action of ZD-6169 and levcromakalim on K ATP channels in UBSM to decrease membrane excitability and contractility. The results support the idea that low levels of K ATP -channel activation have substantial effects on UBSM excitability and contractility.
METHODS

Tissue preparation and organ bath experiments (contractility studies).
Guinea pigs (250-350 g) were euthanized by halothane overdose followed by exsanguination. This procedure was reviewed and approved by the Office of Animal Care Management at the University of Vermont. The entire urinary bladder was removed and placed in ice-cold physiological saline solution (PSS, see below for composition). The bladder was pinned to the bottom of a Petri dish containing nominally Ca 2ϩ -free dissection solution (see below). Small strips (100-to 300-m wide and 3-to 5-mm long) from the detrusor muscle were cut free from the bladder wall and transferred to a Petri dish containing dissection solution. Miniature aluminum clips were placed at each end of the muscle strip to allow mounting of the strip in a tissue bath. Individual strips were placed in thermostatically controlled (37°C) tissue baths (2 ml volume). One end of the strip was attached to a stationary metal hook while the other end was connected to a force-displacement transducer (model BG-10G; Kulite Semiconductor Products) for isometric tension recording. The force generation by the muscle strips was recorded on a computer-based data-acquisition system (Axotape, Axon Instruments, Foster City, CA) and a chart pen recorder. The strips were suspended under a 1-mN tension. There was a 60-to 90-min equilibration period.
To ensure that the effects of ZD-6169 and levcromakalim are not caused by neurotransmitters released from autonomic nerves contained in the muscle strips, experiments were performed in a cocktail consisting of blockers for known neurotransmitter receptors in the UBSM: atropine (1 M), muscarinic antagonist; phentolamine (1 M), ␣-adrenergic antagonist; propranolol (1 M), ␤-adrenergic antagonist; suramin (10 M), purinergic antagonist; and tetrodotoxin (1 M), neuronal Na ϩ -channel blocker (see Ref. 10) . Measurements of membrane potential. For intracellular recordings, several thin strips of UBSM were removed from the serosal surface and pinned to the bottom of a recording chamber. Oxygenated solution was superfused over the tissue (1 ml/min), and the temperature was maintained at 37°C. To facilitate intracellular recordings, tissue movement was reduced by increasing the osmolarity of the superfusing PSS solution with the addition of 350 mM sucrose (8, 12) . Microelectrodes were pulled on a Flaming/Brown gas puller (Sutter Instrument, Novato, CA) and had a resistance of 40-50 M⍀ when filled with 3 M KCl. The transmembrane potential was measured using a Dagan 8500 intracellular amplifier (Dagan, Minneapolis, MN), and the electrical signals were acquired using the Axotape program (Axon Instruments) and stored on magnetic tape using a modified Sony 75ES DAT recorder.
Cell isolation and whole cell K ATP current recordings. To dissociate UBSM cells, three or four tissue strips were placed in 1.5 ml of dissociation solution, which contained 1.0 mg/ml collagenase. The tissue was incubated at 37°C in a rotating water bath for 60 min. After the incubation, the digested tissue was washed several times in dissociation media. The digested tissue was then dispersed with gentle trituration. Several drops of the solution containing the dissociated cells were then placed in a recording chamber. Most cells were elongated and had a bright, shiny appearance when examined using phase-contrast microscopy.
Whole cell currents through K ATP channels were measured using the conventional whole cell configuration of the patch clamp technique, as previously described (1, 2, 7, 16 Under these conditions and a holding potential of Ϫ70 mV, the KATP currents were inward (1, 2) . KATP currents were low-pass filtered at 2 Hz with an eight-pole Bessel filter and digitized at 10 Hz. All experiments were conducted at 22°C.
Solutions and drugs. PSS was made daily and contained (in mM) 119 NaCl, 4.7 KCl, 24 NaHCO 3, 1.2 KH2PO4, 2.5 CaCl2, 1.2 MgSO4, and 11 glucose. The solution was aerated with 95% O2-5% CO2 to obtain pH 7.4. Dissection/dissociation solution contained (in mM) 80 monosodium glutamate, 55 NaCl, 6 KCl, 10 glucose, 10 HEPES, and 2 MgCl2, with pH adjusted to 7.3 with NaOH. ZD-6169 was obtained from AstraZeneca Pharmaceuticals. Atropine, phentolamine, propranolol, suramin, and tetrodotoxin were purchased from Sigma. ZD-6169 and levcromakalim were dissolved in dimethyl sulfoxide and further diluted in PSS. The maximum concentration of dimethyl sulfoxide in the tissue baths was 0.01%. ZD-6169 and levcromakalim were administered directly into the tissue baths as cumulative concentrations.
Statistics. Summary data are presented as means Ϯ SE for n, the number of separate preparations, isolated from different animals. Isolated bladder strips contracted with irregular frequency and amplitude, therefore, a 5-min period of the contraction curve was used to assess contractility. Force integral was calculated by integrating the area under the force-time curve for a period of 5 min. Contractile frequencies, amplitudes, and force integrals are expressed relative to control (absence of pharmacological intervention) values. The last 5 min before drug application (for the control) and the period from the 10th to 15th min for each applied concentration of the drugs were taken as the analysis periods. Statistical analysis of drug effects and the difference between treatment groups were determined using ANOVA where Tukey-Kramer multiple comparisons test was used for multiple comparison. A P value Ͻ0.05 was considered significant. The percent K ATP channel activation was calculated from the concentration-response curves.
RESULTS
Activation of K ATP current by K ATP channel openers ZD-6169 and levcromakalim. The effects of ZD-6169 and levcromakalim on the K ATP currents were investigated at a holding potential of Ϫ70 mV, and the intracellular calcium solution was buffered at 20 nM to minimize activation of voltage-dependent K ϩ channels and large conductance Ca 2ϩ -activated K ϩ channels (see Refs. 1, 2, 7) . Figure 1 illustrates that ZD-6169 (10 M) and levcromakalim (10 M) activate an inward K ATP current, which was reversed by the K ATP -channel inhibitor glibenclamide (10 M). We previously demonstrated that ZD-6169 and levcromakalim activate K ATP currents in UBSM with a one-half activation constant of 1.02 M for ZD-6169 and 2.63 M for levcromakalim and a Hill coefficient of 1.46 for ZD-6169 and 1.62 for levcromakalim, respectively (7) .
Inhibition of UBSM action potentials by low concentrations of ZD-6169. The average resting membrane potential recorded in intact bundles of detrusor UBSM was Ϫ40.3 Ϯ 2.4 mV, which is similar to previous reports (8, 22) . Most of the muscle preparations showed spontaneous electrical activity, exhibited in the form of bursts of action potentials ( Fig. 2A) . ZD-6169, applied at a concentration of 100 nM, which causes ϳ3% activation of K ATP current (see Fig. 4 and DISCUSSION) , caused a small hyperpolarization and inhibition of action potentials (n ϭ 3; Fig. 2A ). Washout of ZD-6169 resulted in a fast recovery of the spontaneous action potentials to the control level ( Fig. 2A) . Small hyperpolarization and inhibition of action potentials could be observed at a concentration of ZD-6169 as low as 10 nM (Fig. 2B) , which corresponds to Ͻ0.2% activation of K ATP currents (see Fig. 4A and DISCUSSION) . Higher concentrations of ZD-6169 (Ն100 nM) further hyperpolarized the membrane and inhibited the smooth muscle action potentials (Fig. 2B) . ZD-6169 at 10 M caused ϳ6 mV hyperpolarization (7, 16) . Levcromakalim also inhibited action potentials (not illustrated).
The membrane potential measurements indicate that the activation of K ATP channels by KCOs is associated with membrane hyperpolarization and inhibition of the action potentials. To understand further how ZD-6169-and levcromakalim-induced changes in K ATP currents and spontaneous electrical activity affect tissue function, we investigated the effect of these K ATP channel openers on spontaneous phasic contractions.
Inhibition of spontaneous phasic contractions by low concentrations of ZD-6169 and levcromakalim.
In UBSM, a phasic contraction reflects an elevation of Ca 2ϩ entry through voltage-dependent Ca 2ϩ channels caused by a burst of action potentials (8, 10) . The amplitude of a phasic contraction depends on the increase in Ca 2ϩ entry caused by membrane depolarization during an action potential, whereas the duration of a phasic contraction depends on the duration of a burst of action potentials. The frequency of phasic contractions should reflect mechanisms that temporarily cause action potentials to cease, such as an increase in K ϩ conductance. Activation of K ATP channels by ZD-6169 and levcromakalim caused a concentration-dependent decrease in phasic contractions. The predominant effect of both ZD-6169 and levcromakalim was to decrease contraction frequency and muscle force integral, but not amplitude or duration (Fig. 3) . A significant inhibition of contraction frequency and muscle force was observed at 30 nM ZD-6169 and levcromakalim. At a concentration of 300 nM ZD-6169 and levcromakalim, the contractions were completely inhibited in five of six preparations. Washout of ZD-6169 and levcromakalim restored the spontaneous contractile activity (Fig. 3A) . Figure 3 , B-E, summarizes the data for the effects of ZD-6169 and levcromakalim on contraction frequency, amplitude, duration, and force integral. ZD-6169 at a concentration of 47 nM and levcromakalim at a concentration of 38 nM caused one-half reduction in UBSM force (Fig. 4) . In contrast, ZD-6169 at 1.02 M and levcromakalim at 2.63 M were required for one-half activation of K ATP currents (7), indicating a 22-and 69-fold difference in sensitivity, respectively (Fig. 4) . The K ATP -channel inhibitor glibenclamide completely reversed the levcromakalimand ZD-6169-induced inhibition of spontaneous phasic contractions (Fig. 5) .
DISCUSSION
The activity of K ATP channels in smooth muscle has been shown to be important in regulating membrane potential and muscle tone (21) . Activation of K ATP channels causes membrane potential hyperpolarization, thereby decreasing smooth muscle tone by reduction in steady-state Ca 2ϩ influx through voltage-dependent Ca 2ϩ channels (18) . UBSM, unlike arterial smooth muscle, exhibits action potentials and phasic contractions. Theoretically, very small changes in K ϩ conductance should be able to decrease UBSM excitability by moving the membrane potential away from the action potential threshold (1). Therefore, we tested the hypothesis that a small degree of activation of K ATP channels would inhibit action potentials and phasic contractions in UBSM.
Previously, ZD-6169 was found to be effective in inhibiting 15 mM K ϩ -induced phasic contractions of detrusor in micromolar concentrations, with an IC 50 of 1.6 M (16, 25) . Levcromakalim has also been reported to inhibit 20 mM K ϩ -induced UBSM contractions with an IC 50 of 0.86 M (5). Therefore, under conditions of elevated K ϩ (15-20 mM), significant K ATP channel activation is required to inhibit phasic contractions. This is not surprising because elevation of K ϩ to 15-20 mM would depolarize the membrane potential and affect the potassium equilibrium potential. In contrast, our results indicate that low percent activation of K ATP channels by ZD-6169 and levcromakalim significantly inhibits action potentials and spontaneous phasic contractions of guinea pig UBSM in physiological external K ϩ concentration (Figs. 2 and 3) . A wide variety of synthetic compounds, including ZD-6169 and levcromakalim, activates K ATP channels in smooth muscle (7, (19) (20) (21) 23) . ZD-6169 and levcromakalim increased K ATP currents with an apparent one-half activation constant of 1.02 and 2.63 M, respectively, and Hill coefficient of 1.46 and 1.62, respec- n ], where k is the concentration for half-maximal effect and n is the Hill coefficient. ZD-6169 k and n values were 1.02 and 1.46 M for KATP currents and 0.047 and 1.26 M for force integral, respectively. Levcromakalim k and n values were 2.63 and 1.62 M for KATP currents and 0.038 and 1.24 M for force integral, respectively. The data for concentration-response curves for the effects of ZD-6169 and levcromakalim on KATP currents were taken from a previous study (7) . s, Current; , muscle force. tively ( Fig. 4 ; see also Ref. 7). We observed statistically significant inhibition of phasic contractions at 30 nM ZD-6169 and levcromakalim (Fig. 3) , which would correspond to activation of Ͻ1% of the K ATP currents (Fig. 4) . ZD-6169 at 300 nM caused complete inhibition of action potentials and phasic contractions (Figs. 2  and 3 ), corresponding to activation of Ͻ15% of the K ATP currents (Fig. 4A) . At the same concentration, levcromakalim also caused complete inhibition of spontaneous phasic contractions (Fig. 3) corresponding to activation of only ϳ3% of the K ATP currents (Fig. 4B) . The fraction of K ATP channels that affects UBSM function is likely to be less than these values. The relationship between ZD-6169 and levcromakalim concentration and K ATP currents was determined in single UBSM cells dialyzed with low intracellular ATP concentration ( Fig. 4 ; see also Ref. 7) . Elevating ATP concentration decreases K ATP currents (1) and increases the one-half activation concentration of the KCOs (21) . Furthermore, it is assumed that ZD-6169 and levcromakalim can increase single-channel open probability to one, which is unlikely (1). Therefore, under physiological conditions, activation of Ͻ1% of the K ATP channels decreases UBSM excitability and phasic contractions. These results support the general concept that regulation of K ATP channels is a potent mechanism to regulate UBSM function.
Perspectives
Urinary incontinence is associated with abnormal detrusor contractions and the involuntary leakage of urine. This urinary bladder dysfunction significantly impairs the lifestyle of millions of people. One type of urinary incontinence is known as unstable bladder or hyperactive bladder. The cause of unstable bladder is thought to lie within the UBSM. Current treatments for unstable bladder are not very effective and have unwanted side effects. In recent years, much effort has been devoted to increasing our understanding of ion channels, such as K ATP channels, that are believed to play a significant role in regulating UBSM excitability. It is hoped that activation of these ion channels would decrease the excitability of UBSM and be useful in the treatment of unstable bladder. To develop ion channel therapeutics that are effective in controlling incontinence, the relationship between ion channel activation and functional effects must be clearly understood. In this study, we used a multifaceted approach to study the effects of K ATP channel openers on single isolated UBSM cells and correlated these findings with functional studies. Together with previous findings (Refs. 1, 2, 7, 16), the present results point to a key role for K ATP channels in the control of membrane potential, action potential generation, and related phasic contractions of UBSM. Our findings suggest that very low concentrations of K ATP -channel openers are sufficient to inhibit UBSM contractions. Thus low-dose applications of K ATP channel openers may cause minimal side effects and be an effective therapeutic for the treatment of certain types of urinary incontinence. 
